- Report
- July 2023
- 99 Pages
Global
From €3500EUR$4,197USD£3,145GBP
- Report
- July 2023
- 96 Pages
Global
From €3500EUR$4,197USD£3,145GBP
- Report
- July 2023
- 108 Pages
Global
From €3500EUR$4,197USD£3,145GBP
- Report
- June 2023
- 108 Pages
Global
From €3500EUR$4,197USD£3,145GBP
- Report
- June 2023
- 130 Pages
Global
From €3500EUR$4,197USD£3,145GBP
- Report
- June 2023
- 114 Pages
Global
From €3500EUR$4,197USD£3,145GBP
- Report
- June 2023
- 113 Pages
Global
From €3500EUR$4,197USD£3,145GBP
- Report
- February 2023
- 100 Pages
Global
From €3500EUR$4,197USD£3,145GBP
- Report
- February 2023
- 88 Pages
Global
From €3500EUR$4,197USD£3,145GBP
- Report
- August 2022
- 81 Pages
Global
From €3500EUR$4,197USD£3,145GBP
- Report
- July 2024
- 153 Pages
Global
From €3796EUR$4,250USD£3,296GBP
- Report
- October 2023
- 146 Pages
Global
From €3707EUR$4,150USD£3,218GBP
- Report
- October 2023
- 146 Pages
Global
From €3707EUR$4,150USD£3,218GBP
- Report
- June 2025
- 46 Pages
United States
From €4462EUR$4,995USD£3,873GBP
- Report
- June 2025
- 26 Pages
Mexico
From €4462EUR$4,995USD£3,873GBP
- Report
- June 2025
- 28 Pages
Brazil
From €4462EUR$4,995USD£3,873GBP
- Report
- June 2025
- 31 Pages
United Kingdom
From €4462EUR$4,995USD£3,873GBP
- Report
- June 2025
- 27 Pages
Russia
From €4462EUR$4,995USD£3,873GBP
- Report
- June 2025
- 27 Pages
Spain
From €4462EUR$4,995USD£3,873GBP
- Report
- June 2025
- 27 Pages
Italy
From €4462EUR$4,995USD£3,873GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more